Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Antiseizure Medications in Preventing Epilepsy After Ischemic Stroke
TCTR20260601016Phase 2Not yet recruiting
- Sponsor
- King Chulalongkorn Memorial Hospital
- Start
- May 2026
- Countries
- 1
01
Overview
Phase 2, randomised trial in epilepsy, sponsored by King Chulalongkorn Memorial Hospital. Planned start May 2026; status: not yet recruiting.
02
Conditions
epilepsy
Beyond the preview
Go deeper on TCTR20260601016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260601016.